Sirolimus in the Management of Complex Infantile Hemangiomas: A State‐of‐the‐Art Review
Pediatric Dermatology · 2025
DOI: 10.1111/pde.70071 ↗At a glance
Übersichtsarbeit in Pediatric Dermatology, 2025. Written by Fabiana C P S Lopes and 4 co-authors. Institution: Department of Medicine/Dermatology, Dell Medical School at the University of Texas at Austin, Austin, Texas, USA. Major MEDLINE topics: Sirolimus, Skin Neoplasms, Hemangioma, Antibiotics, Antineoplastic. Cited 6 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Infantile hemangiomas (IHs) are common, benign vascular tumors frequently managed with beta‐blockers as first‐line therapy. While most IHs respond to propranolol, a subset of severe, refractory, or life‐threatening lesions requires alternative interventions. Sirolimus (rapamycin), a mammalian target of rapamycin (mTOR) pathway inhibitor, has emerged as a promising second‐line treatment option for complicated IHs, particularly those with visceral involvement, airway compromise, functional impairment, or significant cosmetic consequences. This article reviews reported clinical experiences and mechanistic insights supporting the use of sirolimus in managing complex IHs and proposes a protocol to guide patient selection, dosing, and monitoring.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Medicine/Dermatology, Dell Medical School at the University of Texas at Austin, Austin, Texas, USA.
- Dell Children's Medical Group, Ascension Seton, Austin, Texas, USA.
- Department of Pediatrics, Dell Medical School at the University of Texas at Austin, Austin, Texas, USA.
- Pediatric Dermatology Unit, Department of Dermatology, Sheba Medical Center, Ramat Gan, Israel.
- Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv-Yafo, Israel.
ORCID profiles: Fabiana C P S Lopes
Cite
APA
Lopes, F. C. P. S., Levy, M. L., Ruth, J. S., Priola, G., & Greenberger, S. (2025). Sirolimus in the Management of Complex Infantile Hemangiomas: A State‐of‐the‐Art Review. Pediatric Dermatology. https://doi.org/10.1111/pde.70071
Vancouver
Lopes FCPS, Levy ML, Ruth JS, Priola G, Greenberger S. Sirolimus in the Management of Complex Infantile Hemangiomas: A State‐of‐the‐Art Review. Pediatric Dermatology. 2025. doi:10.1111/pde.70071
BibTeX
@article{Lopes2025,
author = {Lopes, Fabiana C P S and Levy, Moise L and Ruth, Jennifer S and Priola, Ginna and Greenberger, Shoshana},
title = {Sirolimus in the Management of Complex Infantile Hemangiomas: A State‐of‐the‐Art Review},
journal = {Pediatric Dermatology},
year = {2025},
doi = {10.1111/pde.70071}
}
EUVIMED